Alliancebernstein L.P. Boosts Stake in Celsius Holdings Inc. $CELH

Key Points

• AllianceBernstein L.P. increased its stake in Celsius Holdings Inc. by 26.3%, now owning 18,045,178 shares valued at approximately $642.8 million.
• Recent analyst ratings reflect a generally positive outlook, with 17 analysts giving it a "Buy" rating and a consensus price target of $58.95.
• Celsius reported a significant 83.9% increase in quarterly revenue compared to the previous year, with earnings per share beating estimates at $0.47.

Alliancebernstein L.P. grew its holdings in Celsius Holdings Inc. (NASDAQ:CELH - Free Report) by 26.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 18,045,178 shares of the company's stock after buying an additional 3,753,055 shares during the quarter. Alliancebernstein L.P. owned approximately 7.00% of Celsius worth $642,769,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Westside Investment Management Inc. bought a new position in shares of Celsius in the 1st quarter worth approximately $32,000. Summit Securities Group LLC bought a new position in shares of Celsius in the 1st quarter worth approximately $34,000. MassMutual Private Wealth & Trust FSB raised its position in shares of Celsius by 255.1% in the 1st quarter. MassMutual Private Wealth & Trust FSB now owns 1,044 shares of the company's stock worth $37,000 after acquiring an additional 750 shares in the last quarter. UMB Bank n.a. raised its position in shares of Celsius by 145.0% in the 1st quarter. UMB Bank n.a. now owns 1,426 shares of the company's stock worth $51,000 after acquiring an additional 844 shares in the last quarter. Finally, Fifth Third Bancorp raised its position in shares of Celsius by 62.9% in the 1st quarter. Fifth Third Bancorp now owns 1,725 shares of the company's stock worth $61,000 after acquiring an additional 666 shares in the last quarter. Institutional investors own 60.95% of the company's stock.

Celsius Stock Performance

Shares of CELH stock traded down $3.12 on Monday, reaching $55.25. The stock had a trading volume of 5,646,465 shares, compared to its average volume of 8,055,714. The company has a 50 day simple moving average of $51.32 and a 200 day simple moving average of $41.24. Celsius Holdings Inc. has a 1 year low of $21.10 and a 1 year high of $63.50. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 2.11. The stock has a market cap of $14.25 billion, a P/E ratio of 149.91, a price-to-earnings-growth ratio of 1.32 and a beta of 1.33.

Celsius (NASDAQ:CELH - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported $0.47 EPS for the quarter, topping analysts' consensus estimates of $0.23 by $0.24. The business had revenue of $739.30 million during the quarter, compared to analysts' expectations of $632.13 million. Celsius had a return on equity of 36.88% and a net margin of 7.91%.The business's quarterly revenue was up 83.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.28 earnings per share. Equities research analysts expect that Celsius Holdings Inc. will post 0.89 EPS for the current year.

Analyst Ratings Changes

Several research analysts have recently issued reports on the company. Bank of America increased their target price on Celsius from $35.00 to $40.00 and gave the stock an "underperform" rating in a research report on Friday, August 8th. UBS Group increased their target price on Celsius from $64.00 to $73.00 and gave the stock a "buy" rating in a research report on Tuesday, September 2nd. Wells Fargo & Company raised their price objective on Celsius from $44.00 to $45.00 and gave the company an "overweight" rating in a research report on Wednesday, June 4th. Stifel Nicolaus raised their price objective on Celsius from $56.00 to $70.00 and gave the company a "buy" rating in a research report on Tuesday, September 2nd. Finally, Stephens reissued an "overweight" rating on shares of Celsius in a report on Monday, August 11th. Seventeen investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Celsius presently has a consensus rating of "Moderate Buy" and a consensus target price of $61.42.

Insiders Place Their Bets

In other news, major shareholder Deborah Desantis sold 100,000 shares of the business's stock in a transaction dated Thursday, July 31st. The stock was sold at an average price of $47.50, for a total value of $4,750,000.00. Following the transaction, the insider directly owned 17,717,770 shares in the company, valued at $841,594,075. The trade was a 0.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Paul H. Storey sold 7,500 shares of the business's stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $60.93, for a total value of $456,975.00. Following the completion of the transaction, the insider owned 37,550 shares in the company, valued at $2,287,921.50. The trade was a 16.65% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 1,123,641 shares of company stock valued at $52,998,580. Insiders own 2.20% of the company's stock.

About Celsius

Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.